VIVE News and Press, Viveve Medical Inc. From 01/03/21

InMode is an outperformer and leader in the growing medical aesthetic devices industry. Its products are made for a variety of purposes including liposuction, skin rejuvenation, cellulite treatment, and more. InMode is an asset-light business with high returns on capital and a flawles...

Viveve Medical ([[VIVE]] -0.4%) regains compliance with the $1.00 minimum bid price requirement for continued listing on The NASDAQ Capital Market.In April, the company was notified that the average closing price of it's American depositary shares was less than $1.00 for a consecuti...

ENGLEWOOD, CO / ACCESSWIRE / December 17, 2020 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's intimate health, announced today that it received notice from The NASDAQ Stock Market LLC (NASDAQ) on December 16, 2020 that the Company has regained complia...

Viveve authorized to increase trial size and introduce new patient selection criteria designed to improve study's power and data to support assessment of primary efficacy endpoint Near-term launch planned for pivotal U.S. PURSUIT trial ENGLEWOOD, CO / ACCESSWIRE / December 10, 202...

Viveve Medical (VIVE) announced 510K approval by the FDA strengthening the supply chain and reduces manufacturing costs for consumable component used with Viveve's Cryogen-cooled Monopolar Radiofrequency technology. "In addition to significant reductions in tip manufacturing costs, the e...

Approval strengthens supply chain and reduces manufacturing costs for consumable component used with Viveve's Cryogen-cooled Monopolar Radiofrequency technology ENGLEWOOD, CO / ACCESSWIRE / December 3, 2020 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on wo...

Viveve Medical, Inc. (VIVE) Q3 2020 Earnings Conference Call November 12, 2020 5:00 PM ET Company Participants Jeannie Swindle – Senior Director of Corporate Communications Scott Durbin – Chief Executive Officer Conference Call Participants Presentation Operator Good afternoon, ...

Viveve Medical (VIVE): Q3 GAAP EPS of -$0.26 beats by $0.27.Revenue of $1.52M (+44.8% Y/Y) beats by $0.52M.Press Release For further details see: Viveve Medical EPS beats by $0.27, beats on revenue

Company shifts strategic focus to stress urinary incontinence Positive feasibility study and preclinical results advance clinical development program targeting treatment of stress urinary incontinence Near-term launch planned for U.S. pivotal PURSUIT trial Company to host con...

ENGLEWOOD, CO / ACCESSWIRE / November 10, 2020 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's intimate health, today announced that Scott Durbin, chief executive officer, will participate in the Alliance Group Partners Virtual Healthcare Symposium on No...